- Motley Fool•4 hours ago
Today was a good day for biotech stocks across the board, including Alnylam Pharmaceuticals.
- Business Wire•5 hours ago
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that management will present company overviews at the Cowen and Company 37th Annual Healthcare Conference on Monday, March 6, 2017 at 2:40 pm ET at the Boston Marriott Copley Place Hotel in Boston, Massachusetts and at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017 at 9:30 am ET at the Loews ...
- Accesswire•5 days agoBlog Coverage Ocular Therapeutix Announced FDA Acceptance of NDA Resubmission for its Product for the Treatment of Ocular Pain
Upcoming AWS Coverage on Alnylam Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / February 23, 2017 / Active Wall St. blog coverage looks at the headline from Ocular Therapeutix, Inc. (NASDAQ: ...
ALNY : Summary for Alnylam Pharmaceuticals, Inc. - Yahoo Finance
Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Ask||72.00 x 100|
|Day's Range||46.60 - 51.55|
|52 Week Range||31.38 - 80.11|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-10.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|